A new strategy for studying In Vitro the drug susceptibility of clinical isolates of human hepatitis B virus
David Durantel, Sandra Carrouée‐Durantel, Bettina Werle‐Lapostolle, Marie‐Noëlle Brunelle, Christian Pichoud, Christian Trépo, Fabien Zoulim – 7 March 2007 – Resistance of hepatitis B virus (HBV) to antivirals has become a major clinical problem. Our objective was to develop a new method for the cloning of naturally occurring HBV genomes and a phenotypic assay capable of assessing HBV drug susceptibility and DNA synthesis capacity in vitro.